I am considering a job at Alcon but have some hesitations now that Novartis is sniping off the business unit. I have seen some of the segments are doing well while others are surviving. With two of their eye drop medications going generic soon. What is the consensus? What are the concerns and what should I consider before looking into this company
company is being spun off....pharma meds stay with Novartis...contacts and surgical only moving forward and both are very healthy business units
